MetaCap

Mentari Therapeutics Earnings

NASDAQ: MTRIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.70-0.545 (-3.57%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Feb 10, 2027

Revenue estimate

$0

Mentari Therapeutics earnings summary

Mentari Therapeutics is scheduled to report earnings on Feb 10, 2027 on revenue of $0. In its most recent report on Nov 2, 2026 (Sep/2026), MTRI posted EPS of $-0.36.

Summary generated from market data by MetaCap's automated system. Methodology

MTRI earnings history

Mentari Therapeutics reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 2, 2026—$-0.36—+19.5%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related